LeJeune Puetz Investment Counsel’s Meridian Bioscience Inc VIVO Stock Holding History

LeJeune Puetz Investment Counsel’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-42,650	Closed	-$751K	–	183
2019 Q1	$751K	Sell	42,650 -600	-1%	-$9.98K	0.41%	72
2018 Q4	$751K	Hold	43,250	–	–	0.47%	65
2018 Q3	$644K	Sell	43,250 -750	-2%	-$11.6K	0.37%	78
2018 Q2	$700K	Sell	44,000 -7,000	-14%	-$104K	0.43%	73
2018 Q1	$724K	Hold	51,000	–	–	0.44%	80
2017 Q4	$714K	Sell	51,000 -750	-1%	-$11K	0.44%	77
2017 Q3	$740K	Hold	51,750	–	–	0.48%	75
2017 Q2	$815K	Hold	51,750	–	–	0.55%	67
2017 Q1	$714K	Sell	51,750 -600	-1%	-$8.39K	0.51%	68
2016 Q4	$927K	Buy	+52,350	New	+$920K	0.71%	54

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LeJeune Puetz Investment Counsel's VIVO Position: Q2 2019 in Review

LeJeune Puetz Investment Counsel sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 42,650 shares — an estimated $751K sold.

LeJeune Puetz Investment Counsel first reported a position in VIVO in Q4 2016 and held it in 10 quarters. The position peaked at $927K in Q4 2016. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

LeJeune Puetz Investment Counsel reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
LeJeune Puetz Investment Counsel sold 42,650 Meridian Bioscience Inc shares in Q2 2019, an estimated $751K.
LeJeune Puetz Investment Counsel first reported a position in Meridian Bioscience Inc in Q4 2016 and held it in 10 quarters.
LeJeune Puetz Investment Counsel's Meridian Bioscience Inc position peaked at $927K in Q4 2016.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on LeJeune Puetz Investment Counsel's 13F filing for Q2 2019, filed 29 Jul 2019.